Skip to main content

Table 1 The clinical and laboratory characteristics of patients with SLE

From: Impacts of FcγRIIB and FcγRIIIA gene polymorphisms on systemic lupus erythematous disease activity index

The clinical and laboratory manifestations

Total (n = 80)

Seizure

10 (12.5%)

Psychosis

4 (5%)

Rash

66 (82.5%)

Organic Brain Syndrome

2 (2.5%)

Visual disturbance

2 (2.5%)

Cranial nerve disorder

3 (3.75%)

Lupus headache

4 (5%)

CVA

0 (0.0%)

Vasculitis

2 (2.5%)

Myositis

4 (5%)

Urinary casts

6 (7.5%)

Hematuria

6 (7.5%)

Proteinuria

8 (10%)

Pyuria

5 (6.25%)

Alopecia

2 (2.5%)

Pleurisy

4 (5%)

Precardia

7 (8.75%)

Low complement

59 (73.75%)

Increased DNA binding

25 (31.25%)

Fever

11 (13.755)

Thrombocytopenia

9 (11.25%)

Leukopenia

27 (26.25%)